Régis Vaillancourt

2.6k total citations
118 papers, 1.4k citations indexed

About

Régis Vaillancourt is a scholar working on Pediatrics, Perinatology and Child Health, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Régis Vaillancourt has authored 118 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pediatrics, Perinatology and Child Health, 28 papers in General Health Professions and 26 papers in Geriatrics and Gerontology. Recurrent topics in Régis Vaillancourt's work include Pharmaceutical Practices and Patient Outcomes (26 papers), Pharmaceutical studies and practices (21 papers) and Health Literacy and Information Accessibility (21 papers). Régis Vaillancourt is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (26 papers), Pharmaceutical studies and practices (21 papers) and Health Literacy and Information Accessibility (21 papers). Régis Vaillancourt collaborates with scholars based in Canada, Poland and United States. Régis Vaillancourt's co-authors include Annie Pouliot, Elena Pascuet, Fida K. Dankar, Piotr Merks, Tyson Roffey, Khaled El Emam, D Heath Stacey, Philippe Suter, Miłosz Jaguszewski and Damian Świeczkowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gene.

In The Last Decade

Régis Vaillancourt

110 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Régis Vaillancourt Canada 20 375 285 252 183 166 118 1.4k
Ros Dowse South Africa 19 770 2.1× 242 0.8× 195 0.8× 118 0.6× 60 0.4× 48 1.4k
Sarah J. Shoemaker United States 13 765 2.0× 348 1.2× 67 0.3× 77 0.4× 198 1.2× 22 1.5k
Bee Hoon Heng Singapore 28 593 1.6× 193 0.7× 66 0.3× 90 0.5× 408 2.5× 74 2.7k
Youn‐Jung Son South Korea 29 843 2.2× 257 0.9× 83 0.3× 63 0.3× 403 2.4× 189 2.7k
Maxim Topaz United States 31 675 1.8× 157 0.6× 109 0.4× 565 3.1× 378 2.3× 184 3.0k
Elizabeth A. Henneman United States 30 671 1.8× 207 0.7× 102 0.4× 43 0.2× 498 3.0× 75 2.5k
Tewodros Eguale United States 27 253 0.7× 579 2.0× 328 1.3× 51 0.3× 222 1.3× 64 2.7k
Kreshnik Hoti Australia 21 560 1.5× 329 1.2× 160 0.6× 34 0.2× 143 0.9× 55 1.3k
Denham L. Phipps United Kingdom 22 335 0.9× 424 1.5× 83 0.3× 31 0.2× 167 1.0× 65 1.6k
Wolfgang Himmel Germany 29 756 2.0× 390 1.4× 348 1.4× 31 0.2× 499 3.0× 128 2.8k

Countries citing papers authored by Régis Vaillancourt

Since Specialization
Citations

This map shows the geographic impact of Régis Vaillancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Régis Vaillancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Régis Vaillancourt more than expected).

Fields of papers citing papers by Régis Vaillancourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Régis Vaillancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Régis Vaillancourt. The network helps show where Régis Vaillancourt may publish in the future.

Co-authorship network of co-authors of Régis Vaillancourt

This figure shows the co-authorship network connecting the top 25 collaborators of Régis Vaillancourt. A scholar is included among the top collaborators of Régis Vaillancourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Régis Vaillancourt. Régis Vaillancourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moles, Rebekah, et al.. (2025). The 2024 updated Basel Statements on the future of hospital pharmacy. American Journal of Health-System Pharmacy. 83(6). 281–293.
2.
Merks, Piotr, Urszula Religioni, Agnieszka Neumann‐Podczaska, et al.. (2024). Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and Cost-Effective Approach to Implementing the New Medicine Service in Community Pharmacies in Poland. Medical Science Monitor. 30. e942923–e942923. 2 indexed citations
3.
Merks, Piotr, Urszula Religioni, Miłosz Jaguszewski, et al.. (2023). Patient satisfaction survey of the “Healthy Heart” pharmaceutical care service – evaluation of pharmacy labelling with pharmaceutical pictograms. BMC Health Services Research. 23(1). 962–962.
4.
Malhotra, Rahul, Ngiap Chuan Tan, Gerald Choon‐Huat Koh, et al.. (2023). Older adult patient preferences for the content and format of prescription medication labels – A best-worst scaling and discrete choice experiment study. Research in Social and Administrative Pharmacy. 19(11). 1455–1464. 3 indexed citations
5.
6.
Merks, Piotr, Damian Świeczkowski, Andreas E. May, et al.. (2020). The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Research in Social and Administrative Pharmacy. 17(1). 1807–1812. 117 indexed citations
7.
McDonald, Katherine, Maxwell Sauder, Nordau Kanigsberg, et al.. (2018). Usability, Satisfaction, and Usefulness of an Illustrated Eczema Action Plan. Journal of Cutaneous Medicine and Surgery. 22(6). 577–582. 6 indexed citations
8.
Vaillancourt, Régis, et al.. (2017). Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review. Pharmacy Practice. 15(2). 887–887. 11 indexed citations
9.
Vaillancourt, Régis, et al.. (2016). Pictograms: Can They Help Patients Recall Medication Safety Instructions?. Visible Language. 50(1). 127. 9 indexed citations
10.
Beringer, Audrey, et al.. (2015). The use of natural health products by paediatric patients in respite care. Paediatrics & Child Health. 20(1). 23–29. 2 indexed citations
11.
Ramphal, Raveena, et al.. (2015). Occupational Exposure to Chemotherapy of Pharmacy Personnel at a Single Centre. The Canadian Journal of Hospital Pharmacy. 68(2). 104–12. 13 indexed citations
12.
Vaillancourt, Régis, et al.. (2014). Use of Methadone for Opioid Weaning in Children: Prescribing Practices and Trends. The Canadian Journal of Hospital Pharmacy. 67(2). 149–56. 6 indexed citations
13.
Vaillancourt, Régis. (2012). Drug Shortages: What Can Hospital Pharmacists Do?. The Canadian Journal of Hospital Pharmacy. 65(3). 175–9. 4 indexed citations
14.
Ellis, Jacqueline, et al.. (2011). Improved Practices for Safe Administration of Intravenous Bolus Morphine in a Pediatric Setting. Pain Management Nursing. 12(3). 146–153. 5 indexed citations
15.
Pascuet, Elena, et al.. (2009). Stability of Celecoxib Oral Suspension. The Canadian Journal of Hospital Pharmacy. 62(6). 464–8. 7 indexed citations
16.
Feber, Janusz, et al.. (2009). Prednisone dosing per body weight or body surface area in children with nephrotic syndrome—is it equivalent?. Pediatric Nephrology. 24(5). 1027–1031. 19 indexed citations
17.
Vaillancourt, Régis, et al.. (2009). Treatment of Medication Intolerance with Lactase in A Complex Palliative Care Patient. Journal of Palliative Care. 25(2). 142–144. 1 indexed citations
18.
Emam, Khaled El, Fida K. Dankar, Elizabeth Jonker, et al.. (2009). A Globally Optimal k-Anonymity Method for the De-Identification of Health Data. Journal of the American Medical Informatics Association. 16(5). 670–682. 153 indexed citations
19.
Vaillancourt, Régis, et al.. (2008). Standard concentrations of high-alert drug infusions across paediatric acute care. Paediatrics & Child Health. 13(5). 371–376. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ros Dowse Breakdown of academic impact, for papers by Sarah J. Shoemaker Breakdown of academic impact, for papers by Bee Hoon Heng Breakdown of academic impact, for papers by Youn‐Jung Son Breakdown of academic impact, for papers by Maxim Topaz Breakdown of academic impact, for papers by Elizabeth A. Henneman Breakdown of academic impact, for papers by Tewodros Eguale Breakdown of academic impact, for papers by Kreshnik Hoti Breakdown of academic impact, for papers by Denham L. Phipps Breakdown of academic impact, for papers by Wolfgang Himmel
Rankless by CCL
2026